Scholarly Index
Robert Paul
University of Missouri–St. Louis; 23,884 total citations; 472 total publications; best world rank #44
University of Missouri–St. Louis
23,884Total citations
472Total publications
87H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| HIV-related health complications and treatments | Lifetime | 44 | US 29 | 99.27 |
| HIV Research and Treatment | Lifetime | 205 | US 131 | 99.36 |
| HIV/AIDS Research and Interventions | Lifetime | 395 | US 238 | 98.98 |
| Neurological Disease Mechanisms and Treatments | Lifetime | 160 | US 65 | 98.58 |
| Dementia and Cognitive Impairment Research | Lifetime | 624 | US 306 | 98.14 |
| Bacterial Infections and Vaccines | Lifetime | 343 | US 136 | 97.31 |
| Advanced Neuroimaging Techniques and Applications | Lifetime | 609 | US 280 | 97.69 |
| Myasthenia Gravis and Thymoma | Lifetime | 271 | US 88 | 96.51 |
| Neuroprotection in Stroke and Neurodegeneration | Lifetime | 490 | US 151 | 95.43 |
| Infectious Encephalopathies and Encephalitis | Lifetime | 981 | US 366 | 80.62 |
| Inflammation biomarkers and pathways | Lifetime | 955 | US 244 | 68.38 |
| HIV Research and Treatment | 2021-2025 | 136 | US 62 | 96.66 |
| HIV-related health complications and treatments | 2021-2025 | 102 | US 44 | 94.67 |
| HIV/AIDS Research and Interventions | 2021-2025 | 796 | US 391 | 93.31 |
| Inflammation biomarkers and pathways | 2021-2025 | 187 | US 29 | 62.42 |